<p>Median (range) or individuals (percent). Statistics using<sup> a</sup>Mann-Whitney <i>U</i> test and <sup>b</sup>χ<sup>2</sup> test.</p
<p>HCV viral genotype was not available for 357 individuals in the HCV mono-infection group and 74 i...
<p>Sensitivity, specificity, positive and negative predictive values of the likelihood achieving SVR...
<p>Chi-squared (<i>χ</i><sup>2</sup>)-test was used to compare differences in distribution.</p
<p>Median (range) or individuals (percent). Statistics using <sup>a</sup>χ<sup>2</sup> test and <sup...
<p>Pretreatment plasma sCD26 concentrations (ng/mL) in patients grouped depending on genotype (Gt). ...
<p>Pretreatment plasma sCD26 concentrations (ng/mL) (<b>A</b>) and DPPIV activity (AU) (<b>B</b>) in...
<p>Data presented as median (25<sup>th</sup>–75th percentile)<sup>a</sup> or n<sup>b</sup>.</p
<p>*Continuous values are indicated in median.</p>#<p>Chi-Square or t-test results.</p><p>CoO = Coun...
<p>The sustained virological response rate was significantly higher in prisoners. However, the diffe...
<p>Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) fo...
<p>Values are expressed as median (IQR)<sup>a</sup> or n<sup>b</sup></p>c<p>n = 173 genotype 1, n = ...
<p>Continuous variables are expressed as median ± interquartile range (IQR). P values are calculated...
<p>*1 patient was lost to follow-up at treatment week 16.</p><p>**One patient was infected with HCV ...
Ppropriate scale i.e, (VL) Serum HCV RNA, No. of copies/ml × by a factor of 2.10, (Sn-nt) normalised...
<p>Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...
<p>HCV viral genotype was not available for 357 individuals in the HCV mono-infection group and 74 i...
<p>Sensitivity, specificity, positive and negative predictive values of the likelihood achieving SVR...
<p>Chi-squared (<i>χ</i><sup>2</sup>)-test was used to compare differences in distribution.</p
<p>Median (range) or individuals (percent). Statistics using <sup>a</sup>χ<sup>2</sup> test and <sup...
<p>Pretreatment plasma sCD26 concentrations (ng/mL) in patients grouped depending on genotype (Gt). ...
<p>Pretreatment plasma sCD26 concentrations (ng/mL) (<b>A</b>) and DPPIV activity (AU) (<b>B</b>) in...
<p>Data presented as median (25<sup>th</sup>–75th percentile)<sup>a</sup> or n<sup>b</sup>.</p
<p>*Continuous values are indicated in median.</p>#<p>Chi-Square or t-test results.</p><p>CoO = Coun...
<p>The sustained virological response rate was significantly higher in prisoners. However, the diffe...
<p>Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) fo...
<p>Values are expressed as median (IQR)<sup>a</sup> or n<sup>b</sup></p>c<p>n = 173 genotype 1, n = ...
<p>Continuous variables are expressed as median ± interquartile range (IQR). P values are calculated...
<p>*1 patient was lost to follow-up at treatment week 16.</p><p>**One patient was infected with HCV ...
Ppropriate scale i.e, (VL) Serum HCV RNA, No. of copies/ml × by a factor of 2.10, (Sn-nt) normalised...
<p>Plasma samples from 39 patients, taken prior to treatment initiation with pegylated interferon-α ...
<p>HCV viral genotype was not available for 357 individuals in the HCV mono-infection group and 74 i...
<p>Sensitivity, specificity, positive and negative predictive values of the likelihood achieving SVR...
<p>Chi-squared (<i>χ</i><sup>2</sup>)-test was used to compare differences in distribution.</p